产品介绍：
产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
生化/生理作用
毒蕈碱型乙酰胆碱受体拮抗剂；可能通过下调生长促进基因，抑制膀胱平滑肌细胞的增殖。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
基本信息
| 经验(实验)分子式 | C22H31NO3 · HCl |
| 分子量 | 393.95 |
| MDL编号 | MFCD00072150 |
产品性质
| 等级 | certified reference material pharmaceutical secondary standard |
| 描述 | Pharmaceutical Secondary Standard; Certified Reference Material |
| 形式 | solid |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 500 mg |
| 药典可追溯性 | traceable to PhEur O0288000 traceable to USP 1485103 |
| 储存温度 | 2-30℃ |
| SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 |
| InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H |
| InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 |
| 预防措施声明 | P264 - P270 - P301 + P312 - P501 |
| 危险分类 | Acute Tox. 4 Oral |
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
